PROTECTIVE EFFICACY OF BCG AGAINST LEPROSY IN NORTHERN MALAWI
暂无分享,去创建一个
J. Clarkson | P. E. M Fine | N Maine | J. M Ponnighaus | J. A Clarkson | L Bliss | L. Bliss | J. Ponnighaus | N. Maine | P. Fine
[1] James J Schlesselman. Case-Control Studies: Design, Conduct, Analysis , 1982 .
[2] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[3] I. Sutherland,et al. BCG vaccination of children against leprosy in Uganda: final results , 1981, Journal of Hygiene.
[4] G. C. Scott,et al. Untreated leprosy: probability for shifts in Ridley-Jopling classification. Development of "flares", or disappearance of clinically apparent disease. , 1976, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.
[5] P G Smith,et al. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. , 1984, International journal of epidemiology.
[6] W. Willett,et al. A case-control study of BCG and childhood tuberculosis in Cali, Colombia. , 1985, International journal of epidemiology.
[7] L. M. Bechelli,et al. BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma. , 1985, Bulletin of the World Health Organization.
[8] P. Fine. Leprosy: the epidemiology of a slow bacterium. , 1982, Epidemiologic reviews.
[9] Trial of BCG vaccines in south India for tuberculosis prevention. , 1979, The Indian journal of medical research.
[10] P. Fine,et al. Histopathological examination of skin biopsies from an epidemiological study of leprosy in northern Malawi. , 1987, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.